Thymic dependent leukemia in AKR mice: requirement of an intact thymic stroma

G. Fernandes, O. Stutman, E. J. Yunis

Research output: Contribution to journalArticle

Abstract

Neonatal thymectomy is known to prevent lymphatic leukemia in AKR mice, but intact thymus graft from syngeneic mice completely restores the capacity of these mice to produce the disease. The present experiments were designed to study the leukogenic role of spleen cells and thymocytes. Normal AKR mice developed 90% leukemia (mean 275 days), whereas neonatal thymectomy induced 15% wasting disease and 0% leukemia until 400 days of observation period. However, 2 wk old normal and thymectomized mice injected i.p. with spleen cells (50 x 106) from 2 mth old AKR mice developed (mean 259 days) leukemia: 93% in normal animals and only 17% (mean 387 days) in thymectomized mice. In contrast, thymectomized mice injected with thymus cells (200 x 106) had 0% death at 400 days. In addition, thymectomized AKR mice were able to reject allogenic skin grafts within 13.4 days as compared to 9.4 days for normal mice. This may suggest that thymectomy at birth has not drastically reduced the immunocompetent cells from AKR mice. Preleukemic spleen cells from 5 mth old AKR mice significantly accelerated the disease both in normal (mean 136 days) and thymectomized animals (mean 226 days). The underlying mechanism of the latter results may have been due to the larger concentration of leukemia virus in 5 mth old spleen cells. However, these experiments suggest the need of an intact thymic architecture to permit the thymic dependent cells (young) to transform as neoplastic cells in AKR mice.

Original languageEnglish (US)
JournalAmerican Journal of Pathology
Volume78
Issue number1
StatePublished - 1975
Externally publishedYes

Fingerprint

Inbred AKR Mouse
Leukemia
Thymectomy
Spleen
Thymus Gland
Wasting Syndrome
Transplants
Thymocytes
Observation
Parturition
Viruses
Skin

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Thymic dependent leukemia in AKR mice : requirement of an intact thymic stroma. / Fernandes, G.; Stutman, O.; Yunis, E. J.

In: American Journal of Pathology, Vol. 78, No. 1, 1975.

Research output: Contribution to journalArticle

Fernandes, G. ; Stutman, O. ; Yunis, E. J. / Thymic dependent leukemia in AKR mice : requirement of an intact thymic stroma. In: American Journal of Pathology. 1975 ; Vol. 78, No. 1.
@article{50d329ba317c475580374d2e733d69de,
title = "Thymic dependent leukemia in AKR mice: requirement of an intact thymic stroma",
abstract = "Neonatal thymectomy is known to prevent lymphatic leukemia in AKR mice, but intact thymus graft from syngeneic mice completely restores the capacity of these mice to produce the disease. The present experiments were designed to study the leukogenic role of spleen cells and thymocytes. Normal AKR mice developed 90{\%} leukemia (mean 275 days), whereas neonatal thymectomy induced 15{\%} wasting disease and 0{\%} leukemia until 400 days of observation period. However, 2 wk old normal and thymectomized mice injected i.p. with spleen cells (50 x 106) from 2 mth old AKR mice developed (mean 259 days) leukemia: 93{\%} in normal animals and only 17{\%} (mean 387 days) in thymectomized mice. In contrast, thymectomized mice injected with thymus cells (200 x 106) had 0{\%} death at 400 days. In addition, thymectomized AKR mice were able to reject allogenic skin grafts within 13.4 days as compared to 9.4 days for normal mice. This may suggest that thymectomy at birth has not drastically reduced the immunocompetent cells from AKR mice. Preleukemic spleen cells from 5 mth old AKR mice significantly accelerated the disease both in normal (mean 136 days) and thymectomized animals (mean 226 days). The underlying mechanism of the latter results may have been due to the larger concentration of leukemia virus in 5 mth old spleen cells. However, these experiments suggest the need of an intact thymic architecture to permit the thymic dependent cells (young) to transform as neoplastic cells in AKR mice.",
author = "G. Fernandes and O. Stutman and Yunis, {E. J.}",
year = "1975",
language = "English (US)",
volume = "78",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Thymic dependent leukemia in AKR mice

T2 - requirement of an intact thymic stroma

AU - Fernandes, G.

AU - Stutman, O.

AU - Yunis, E. J.

PY - 1975

Y1 - 1975

N2 - Neonatal thymectomy is known to prevent lymphatic leukemia in AKR mice, but intact thymus graft from syngeneic mice completely restores the capacity of these mice to produce the disease. The present experiments were designed to study the leukogenic role of spleen cells and thymocytes. Normal AKR mice developed 90% leukemia (mean 275 days), whereas neonatal thymectomy induced 15% wasting disease and 0% leukemia until 400 days of observation period. However, 2 wk old normal and thymectomized mice injected i.p. with spleen cells (50 x 106) from 2 mth old AKR mice developed (mean 259 days) leukemia: 93% in normal animals and only 17% (mean 387 days) in thymectomized mice. In contrast, thymectomized mice injected with thymus cells (200 x 106) had 0% death at 400 days. In addition, thymectomized AKR mice were able to reject allogenic skin grafts within 13.4 days as compared to 9.4 days for normal mice. This may suggest that thymectomy at birth has not drastically reduced the immunocompetent cells from AKR mice. Preleukemic spleen cells from 5 mth old AKR mice significantly accelerated the disease both in normal (mean 136 days) and thymectomized animals (mean 226 days). The underlying mechanism of the latter results may have been due to the larger concentration of leukemia virus in 5 mth old spleen cells. However, these experiments suggest the need of an intact thymic architecture to permit the thymic dependent cells (young) to transform as neoplastic cells in AKR mice.

AB - Neonatal thymectomy is known to prevent lymphatic leukemia in AKR mice, but intact thymus graft from syngeneic mice completely restores the capacity of these mice to produce the disease. The present experiments were designed to study the leukogenic role of spleen cells and thymocytes. Normal AKR mice developed 90% leukemia (mean 275 days), whereas neonatal thymectomy induced 15% wasting disease and 0% leukemia until 400 days of observation period. However, 2 wk old normal and thymectomized mice injected i.p. with spleen cells (50 x 106) from 2 mth old AKR mice developed (mean 259 days) leukemia: 93% in normal animals and only 17% (mean 387 days) in thymectomized mice. In contrast, thymectomized mice injected with thymus cells (200 x 106) had 0% death at 400 days. In addition, thymectomized AKR mice were able to reject allogenic skin grafts within 13.4 days as compared to 9.4 days for normal mice. This may suggest that thymectomy at birth has not drastically reduced the immunocompetent cells from AKR mice. Preleukemic spleen cells from 5 mth old AKR mice significantly accelerated the disease both in normal (mean 136 days) and thymectomized animals (mean 226 days). The underlying mechanism of the latter results may have been due to the larger concentration of leukemia virus in 5 mth old spleen cells. However, these experiments suggest the need of an intact thymic architecture to permit the thymic dependent cells (young) to transform as neoplastic cells in AKR mice.

UR - http://www.scopus.com/inward/record.url?scp=0016428321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016428321&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0016428321

VL - 78

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 1

ER -